{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/dea/actions/recent","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.federalregister.gov/agencies/drug-enforcement-administration","generated_at":"2026-05-21T07:07:35.328Z"},"count":50,"items":[{"document_number":"2026-09930","title":"Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC","publication_date":"2026-05-18","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 28620","party_name":"Benuvia Operations, LLC","html_url":"https://www.federalregister.gov/documents/2026/05/18/2026-09930/bulk-manufacturer-of-controlled-substances-application-benuvia-operations-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-09930"},{"document_number":"2026-09566","title":"Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I","publication_date":"2026-05-13","fr_type":"Rule","action_label":"Final rule.","category":"scheduling","citation":"91 FR 26913","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/05/13/2026-09566/schedules-of-controlled-substances-placement-of-cumyl-pegaclone-in-schedule-i","canonical_url":"https://api.ai-analytics.org/dea-action/2026-09566"},{"document_number":"2026-08595","title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance","publication_date":"2026-05-04","fr_type":"Rule","action_label":"Final rule.","category":"other","citation":"91 FR 23913","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08595"},{"document_number":"2026-08585","title":"Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.","publication_date":"2026-05-04","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 24009","party_name":"Patheon Pharmaceuticals Inc.","html_url":"https://www.federalregister.gov/documents/2026/05/04/2026-08585/bulk-manufacturer-of-controlled-substances-application-patheon-pharmaceuticals-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08585"},{"document_number":"2026-08586","title":"Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.","publication_date":"2026-05-04","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 24008","party_name":"ANI Pharmaceuticals Inc.","html_url":"https://www.federalregister.gov/documents/2026/05/04/2026-08586/bulk-manufacturer-of-controlled-substances-application-ani-pharmaceuticals-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08586"},{"document_number":"2026-08588","title":"Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.","publication_date":"2026-05-04","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 24008","party_name":"Patheon API Inc.","html_url":"https://www.federalregister.gov/documents/2026/05/04/2026-08588/bulk-manufacturer-of-controlled-substances-application-patheon-api-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08588"},{"document_number":"2026-08587","title":"Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.","publication_date":"2026-05-04","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 24008","party_name":"ANI Pharmaceuticals Inc.","html_url":"https://www.federalregister.gov/documents/2026/05/04/2026-08587/importer-of-controlled-substances-application-ani-pharmaceuticals-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08587"},{"document_number":"2026-08517","title":"Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I","publication_date":"2026-05-01","fr_type":"Rule","action_label":"Final rule.","category":"scheduling","citation":"91 FR 23359","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/05/01/2026-08517/schedules-of-controlled-substances-placement-of-4f-mdmb-butica-adb-4en-pinaca-5f-edmb-pica-and","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08517"},{"document_number":"2026-08176","title":"Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements","publication_date":"2026-04-28","fr_type":"Rule","action_label":"Final rule.","category":"scheduling","citation":"91 FR 22714","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/28/2026-08176/schedules-of-controlled-substances-rescheduling-of-food-and-drug-administration-approved-products","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08176"},{"document_number":"2026-08178","title":"Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal","publication_date":"2026-04-28","fr_type":"Proposed Rule","action_label":"Notice of hearing on proposed rulemaking; withdrawal.","category":"scheduling","citation":"91 FR 22778","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/28/2026-08178/schedules-of-controlled-substances-rescheduling-of-marijuana-withdrawal","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08178"},{"document_number":"2026-08177","title":"Schedules of Controlled Substances: Rescheduling of Marijuana","publication_date":"2026-04-28","fr_type":"Proposed Rule","action_label":"Notice of hearing on proposed rulemaking.","category":"scheduling","citation":"91 FR 22777","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/28/2026-08177/schedules-of-controlled-substances-rescheduling-of-marijuana","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08177"},{"document_number":"2026-08104","title":"Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I","publication_date":"2026-04-24","fr_type":"Rule","action_label":"Final rule.","category":"scheduling","citation":"91 FR 21958","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/24/2026-08104/schedules-of-controlled-substances-placement-of-mdmb-4en-pinaca-in-schedule-i","canonical_url":"https://api.ai-analytics.org/dea-action/2026-08104"},{"document_number":"2026-07696","title":"Importer of Controlled Substances Application: Leading Pharma LLC","publication_date":"2026-04-21","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 21314","party_name":"Leading Pharma LLC","html_url":"https://www.federalregister.gov/documents/2026/04/21/2026-07696/importer-of-controlled-substances-application-leading-pharma-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07696"},{"document_number":"2026-07697","title":"Importer of Controlled Substances Application: VA Cooperative Studies Program","publication_date":"2026-04-21","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 21314","party_name":"VA Cooperative Studies Program","html_url":"https://www.federalregister.gov/documents/2026/04/21/2026-07697/importer-of-controlled-substances-application-va-cooperative-studies-program","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07697"},{"document_number":"2026-07698","title":"Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences","publication_date":"2026-04-21","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 21313","party_name":"AJNA Biosciences","html_url":"https://www.federalregister.gov/documents/2026/04/21/2026-07698/bulk-manufacturer-of-controlled-substances-application-ajna-biosciences","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07698"},{"document_number":"2026-07558","title":"Importer of Controlled Substances Application: LTS Therapy Systems, LLC","publication_date":"2026-04-17","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 20703","party_name":"LTS Therapy Systems, LLC","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07558/importer-of-controlled-substances-application-lts-therapy-systems-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07558"},{"document_number":"2026-07559","title":"Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC","publication_date":"2026-04-17","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 20702","party_name":"Quagen Pharmaceuticals LLC","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07559/importer-of-controlled-substances-application-quagen-pharmaceuticals-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07559"},{"document_number":"2026-07562","title":"Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc.","publication_date":"2026-04-17","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 20702","party_name":"Usona Institute, Inc.","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07562/bulk-manufacturer-of-controlled-substances-application-usona-institute-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07562"},{"document_number":"2026-07561","title":"Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals","publication_date":"2026-04-17","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 20703","party_name":"Royal Emerald Pharmaceuticals","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07561/importer-of-controlled-substances-application-royal-emerald-pharmaceuticals","canonical_url":"https://api.ai-analytics.org/dea-action/2026-07561"},{"document_number":"2026-06523","title":"Designation of P2P Methyl Glycidic Acid as a List I Chemical","publication_date":"2026-04-03","fr_type":"Rule","action_label":"Final rule.","category":"other","citation":"91 FR 16831","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06523/designation-of-p2p-methyl-glycidic-acid-as-a-list-i-chemical","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06523"},{"document_number":"2026-06522","title":"Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute","publication_date":"2026-04-03","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16975","party_name":"Research Triangle Institute","html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06522/bulk-manufacturer-of-controlled-substances-application-research-triangle-institute","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06522"},{"document_number":"2026-06520","title":"Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC","publication_date":"2026-04-03","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16969","party_name":"Blue Rabbit Veterinary LLC","html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06520/importer-of-controlled-substances-application-blue-rabbit-veterinary-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06520"},{"document_number":"2026-06524","title":"Bulk Manufacturer of Controlled Substances Application: Purisys, LLC","publication_date":"2026-04-03","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16974","party_name":"Purisys, LLC","html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06524/bulk-manufacturer-of-controlled-substances-application-purisys-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06524"},{"document_number":"2026-06521","title":"Importer of Controlled Substances Application: Lipomed/LGC Standards","publication_date":"2026-04-03","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16969","party_name":"Lipomed/LGC Standards","html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06521/importer-of-controlled-substances-application-lipomedlgc-standards","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06521"},{"document_number":"2026-06258","title":"Importer of Controlled Substances Application: Fisher Clinical Services, Inc.","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16244","party_name":"Fisher Clinical Services, Inc.","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06258/importer-of-controlled-substances-application-fisher-clinical-services-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06258"},{"document_number":"2026-06256","title":"Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16243","party_name":"Royal Emerald Pharmaceuticals","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06256/bulk-manufacturer-of-controlled-substances-application-royal-emerald-pharmaceuticals","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06256"},{"document_number":"2026-06261","title":"Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16243","party_name":"Pharmaron Manufacturing Services (US) LLC","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06261/bulk-manufacturer-of-controlled-substances-application-pharmaron-manufacturing-services-us-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06261"},{"document_number":"2026-06311","title":"Importer of Controlled Substances Application: Research Triangle Institute","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16237","party_name":"Research Triangle Institute","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06311/importer-of-controlled-substances-application-research-triangle-institute","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06311"},{"document_number":"2026-06259","title":"Importer of Controlled Substances Application: Indivior Manufacturing LLC","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16237","party_name":"Indivior Manufacturing LLC","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06259/importer-of-controlled-substances-application-indivior-manufacturing-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06259"},{"document_number":"C1-2026-02288","title":"Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017","publication_date":"2026-04-01","fr_type":"Rule","action_label":null,"category":"other","citation":"91 FR 16167","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/04/01/C1-2026-02288/registering-emergency-medical-services-agencies-under-the-protecting-patient-access-to-emergency","canonical_url":"https://api.ai-analytics.org/dea-action/C1-2026-02288"},{"document_number":"2026-06260","title":"Importer of Controlled Substances Application: Sterling Wisconsin, LLC","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16244","party_name":"Sterling Wisconsin, LLC","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06260/importer-of-controlled-substances-application-sterling-wisconsin-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06260"},{"document_number":"2026-06257","title":"Importer of Controlled Substances Application: Fisher Clinical Services, Inc.","publication_date":"2026-04-01","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 16243","party_name":"Fisher Clinical Services, Inc.","html_url":"https://www.federalregister.gov/documents/2026/04/01/2026-06257/importer-of-controlled-substances-application-fisher-clinical-services-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06257"},{"document_number":"2026-06051","title":"Importer of Controlled Substances Application: Usona Institute","publication_date":"2026-03-30","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 15637","party_name":"Usona Institute","html_url":"https://www.federalregister.gov/documents/2026/03/30/2026-06051/importer-of-controlled-substances-application-usona-institute","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06051"},{"document_number":"2026-06052","title":"Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC","publication_date":"2026-03-30","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 15636","party_name":"Chemtos, LLC","html_url":"https://www.federalregister.gov/documents/2026/03/30/2026-06052/bulk-manufacturer-of-controlled-substances-application-chemtos-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06052"},{"document_number":"2026-06053","title":"Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC","publication_date":"2026-03-30","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 15637","party_name":"Pharmaron Manufacturing Services (US) LLC","html_url":"https://www.federalregister.gov/documents/2026/03/30/2026-06053/importer-of-controlled-substances-application-pharmaron-manufacturing-services-us-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-06053"},{"document_number":"2026-05912","title":"Bulk Manufacturer of Controlled Substances Application: SpecGx LLC","publication_date":"2026-03-26","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 14721","party_name":"SpecGx LLC","html_url":"https://www.federalregister.gov/documents/2026/03/26/2026-05912/bulk-manufacturer-of-controlled-substances-application-specgx-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05912"},{"document_number":"2026-05618","title":"Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I","publication_date":"2026-03-23","fr_type":"Rule","action_label":"Final rule.","category":"scheduling","citation":"91 FR 13733","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/03/23/2026-05618/schedules-of-controlled-substances-placement-of-3-methoxyphencyclidine","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05618"},{"document_number":"2026-05482","title":"Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments","publication_date":"2026-03-20","fr_type":"Rule","action_label":"Final rule, technical amendment.","category":"other","citation":"91 FR 13498","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/03/20/2026-05482/ordering-schedule-i-and-ii-controlled-substances-using-dea-form-222-technical-amendments","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05482"},{"document_number":"2026-05486","title":"Exempt Chemical Preparations Under the Controlled Substances Act","publication_date":"2026-03-20","fr_type":"Notice","action_label":"Exemption orders with opportunity for comment.","category":"other","citation":"91 FR 13610","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/03/20/2026-05486/exempt-chemical-preparations-under-the-controlled-substances-act","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05486"},{"document_number":"2026-05360","title":"Importer of Controlled Substances Application: Pisgah Laboratories Inc","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13339","party_name":"Pisgah Laboratories Inc","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05360/importer-of-controlled-substances-application-pisgah-laboratories-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05360"},{"document_number":"2026-05357","title":"Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13338","party_name":"Sterling Wisconsin, LLC","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05357/bulk-manufacturer-of-controlled-substances-application-sterling-wisconsin-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05357"},{"document_number":"2026-05359","title":"Importer of Controlled Substances Application: United States Pharmacopeial Convention","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13338","party_name":"United States Pharmacopeial Convention","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05359/importer-of-controlled-substances-application-united-states-pharmacopeial-convention","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05359"},{"document_number":"2026-05355","title":"Importer of Controlled Substances Application: Patheon API Services, Inc.","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13337","party_name":"Patheon API Services, Inc.","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05355/importer-of-controlled-substances-application-patheon-api-services-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05355"},{"document_number":"2026-05358","title":"Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13337","party_name":"Siegfried Grafton, Inc.","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05358/bulk-manufacturer-of-controlled-substances-application-siegfried-grafton-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05358"},{"document_number":"2026-05353","title":"Importer of Controlled Substances Application: SpecGx LLC","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13336","party_name":"SpecGx LLC","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05353/importer-of-controlled-substances-application-specgx-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05353"},{"document_number":"2026-05356","title":"Importer of Controlled Substances Application: Siegfried Grafton, Inc.","publication_date":"2026-03-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 13336","party_name":"Siegfried Grafton, Inc.","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05356/importer-of-controlled-substances-application-siegfried-grafton-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05356"},{"document_number":"2026-05064","title":"Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I","publication_date":"2026-03-16","fr_type":"Rule","action_label":"Temporary amendment; temporary scheduling order.","category":"scheduling","citation":"91 FR 12504","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/03/16/2026-05064/schedules-of-controlled-substances-temporary-placement-of-bromazolam-in-schedule-i","canonical_url":"https://api.ai-analytics.org/dea-action/2026-05064"},{"document_number":"2026-04969","title":"Bulk Manufacturer of Controlled Substances Application: Stepan Company","publication_date":"2026-03-13","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 12447","party_name":"Stepan Company","html_url":"https://www.federalregister.gov/documents/2026/03/13/2026-04969/bulk-manufacturer-of-controlled-substances-application-stepan-company","canonical_url":"https://api.ai-analytics.org/dea-action/2026-04969"},{"document_number":"2026-04972","title":"Importer of Controlled Substances Application: Lonza Tampa, LLC","publication_date":"2026-03-13","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 12447","party_name":"Lonza Tampa, LLC","html_url":"https://www.federalregister.gov/documents/2026/03/13/2026-04972/importer-of-controlled-substances-application-lonza-tampa-llc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-04972"},{"document_number":"2026-04971","title":"Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc","publication_date":"2026-03-13","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 12446","party_name":"Pisgah Laboratories Inc","html_url":"https://www.federalregister.gov/documents/2026/03/13/2026-04971/bulk-manufacturer-of-controlled-substances-application-pisgah-laboratories-inc","canonical_url":"https://api.ai-analytics.org/dea-action/2026-04971"}]}